España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sight Sciences
SGHT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.53
-0.23
-8.33%
At close: -
$2.53
0.00
0.00%
After Hours: 4:01 PM EDT
Get Report
Comment
Q4 2024 Earnings in 11 days from now on Wed Mar 5th, after the market close
Sight Sciences (SGHT) Forecast
News
Earnings
Sight Sciences (SGHT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sight Sciences (NASDAQ:SGHT) Stock
Sight Sciences Stock (NASDAQ: SGHT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 06, 2025
What 6 Analyst Ratings Have To Say About Sight Sciences
Benzinga Insights
Stifel Maintains Buy on Sight Sciences, Lower...
Benzinga Newsdesk
Monday, January 27, 2025
UBS Maintains Buy on Sight Sciences, Lowers P...
Benzinga Newsdesk
Wednesday, January 15, 2025
Expert Outlook: Sight Sciences Through The Eyes Of 5 Analysts
Benzinga Insights
Lake Street Maintains Hold on Sight Sciences,...
Benzinga Newsdesk
Tuesday, January 14, 2025
Needham Reiterates Hold on Sight Sciencesto H...
Benzinga Newsdesk
Sight Sciences Announces Preliminary Q4 2024 ...
Benzinga Newsdesk
Tuesday, January 07, 2025
Sight Sciences Announces Publication Of Real-...
Benzinga Newsdesk
Thursday, December 19, 2024
Sight Sciences Announces The Results Of A Bud...
Benzinga Newsdesk
Wednesday, December 11, 2024
Where Sight Sciences Stands With Analysts
Benzinga Insights
Citigroup Maintains Neutral on Sight Sciences...
Benzinga Newsdesk
Friday, December 06, 2024
UBS Initiates Coverage On Sight Sciences with...
Benzinga Newsdesk
Monday, November 11, 2024
Morgan Stanley Maintains Equal-Weight on Sigh...
Benzinga Newsdesk
Friday, November 08, 2024
Piper Sandler Reiterates Neutral on Sight Sci...
Benzinga Newsdesk
Needham Reiterates Hold on Sight Sciences
Benzinga Newsdesk
Thursday, November 07, 2024
Sight Sciences Affirms FY2024 Sales Guidance ...
Benzinga Newsdesk
Sight Sciences Sees FY24 Revenue $81M-$83M Vs...
Benzinga Newsdesk
Sight Sciences Q3 2024 GAAP EPS $(0.22) Beats...
Benzinga Newsdesk
Tuesday, November 05, 2024
Top 3 Health Care Stocks You'll Regret Missing In November
Avi Kapoor
Monday, October 14, 2024
Sight Sciences Reports Publication Of New Stu...
Benzinga Newsdesk
Wednesday, August 21, 2024
Lake Street Initiates Coverage On Sight Scien...
Benzinga Newsdesk
Friday, August 02, 2024
Sight Sciences shares are trading lower after...
Benzinga Newsdesk
Needham Reiterates Hold on Sight Sciences
Benzinga Newsdesk
Thursday, August 01, 2024
Sight Sciences Narrows FY24 Revenue Guidance ...
Benzinga Newsdesk
Sight Sciences Continues To Expect Double-Dig...
Benzinga Newsdesk
Sight Sciences Q2 2024 GAAP EPS $(0.25) Beats...
Benzinga Newsdesk
Monday, July 15, 2024
Morgan Stanley Maintains Equal-Weight on Sigh...
Benzinga Newsdesk
Thursday, July 11, 2024
Citigroup Maintains Neutral on Sight Sciences...
Benzinga Newsdesk
Tuesday, May 28, 2024
Sight Sciences Announces Publication Of Twelv...
Benzinga Newsdesk
Sight Sciences Announces The Results As Publi...
Benzinga Newsdesk
Friday, May 03, 2024
Piper Sandler Reiterates Neutral on Sight Sci...
Benzinga Newsdesk
Needham Reiterates Hold on Sight Sciences
Benzinga Newsdesk
Thursday, May 02, 2024
Sight Sciences Reaffirms FY24 Revenue Guidanc...
Benzinga Newsdesk
Sight Sciences Q1 2024 GAAP EPS $(0.33) Misse...
Benzinga Newsdesk
Monday, April 29, 2024
Sight Sciences shares are trading higher afte...
Benzinga Newsdesk
Sight Sciences Announces $34M Patent Infringe...
Benzinga Newsdesk
Wednesday, April 10, 2024
Sight Sciences Announces The Publication Of L...
Benzinga Newsdesk
Needham Reiterates Hold on Sight Sciences
Benzinga Newsdesk
Wednesday, April 03, 2024
Sight Sciences shares are trading higher afte...
Benzinga Newsdesk
Tuesday, April 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Sight Sciences Announces The Results Of The 3...
Benzinga Newsdesk
Friday, March 08, 2024
Stifel Maintains Buy on Sight Sciences, Raise...
Benzinga Newsdesk
Thursday, March 07, 2024
Sight Sciences Projects 2024 Revenue $81M-$85...
Benzinga Newsdesk
Sight Sciences: Q4 Earnings Insights
Benzinga Insights
Sight Sciences Q4 2023 GAAP EPS $(0.220) Beat...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
Sight Sciences's Earnings: A Preview
Benzinga Insights
Wednesday, February 14, 2024
Sight Sciences Announces European Launch Of T...
Benzinga Newsdesk
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, January 08, 2024
Sight Sciences Expects FY23 Total Revenue Of ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
